Attorney General Paxton Secures $7.5 Million Settlement from Tris Pharma for Misrepresenting the Efficacy of ADHD Drug for Kids
October 01, 2026
October 01, 2026
AUSTIN, Texas, Oct. 1 -- Texas Attorney General Ken Paxton issued the following news release:
* * *
Attorney General Paxton Secures $7.5 Million Settlement from Tris Pharma for Misrepresenting the Efficacy of ADHD Drug for Kids
*
Attorney General Ken Paxton secured a $7.5 million settlement with Tris Pharmaceuticals ("Tris Pharma"), holding the company accountable for misrepresenting the efficacy of Dyanavel XR, an attention-deficit/h . . .
* * *
Attorney General Paxton Secures $7.5 Million Settlement from Tris Pharma for Misrepresenting the Efficacy of ADHD Drug for Kids
*
Attorney General Ken Paxton secured a $7.5 million settlement with Tris Pharmaceuticals ("Tris Pharma"), holding the company accountable for misrepresenting the efficacy of Dyanavel XR, an attention-deficit/h . . .
